摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,5-二氮杂双环[3.3.1]壬烷 | 281-17-4

中文名称
1,5-二氮杂双环[3.3.1]壬烷
中文别名
——
英文名称
1,5-Diazabicyclo<3,3,1>nonan
英文别名
1,5-Diazabicyclo[3.3.1]nonane
1,5-二氮杂双环[3.3.1]壬烷化学式
CAS
281-17-4
化学式
C7H14N2
mdl
——
分子量
126.202
InChiKey
HYTQTNKKOHXGKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    6.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

反应信息

  • 作为产物:
    描述:
    1,5-diazoniatricyclo<3.3.3.0>undecane bistetrafluoroborate 在 tetrafluoroboric acid 作用下, 反应 0.5h, 生成 1,5-二氮杂环辛烷1,5-二氮杂双环[3.3.1]壬烷
    参考文献:
    名称:
    在重氮丙螺系列中的肼离子去质子化反应,形成桥头亚胺离子;外部和分子内捕获
    摘要:
    描述了六烷基肼基阳离子与碱和亲核试剂的反应。1,N-三唑[3.3.2.0]癸烷(1)通过S N 2攻击具有开环(C + +裂解)的四元环而迅速水解。在所有其他情况下,在α–C处伴随N + –N +裂解(E 2反应)的去质子化是唯一的主要过程。该顺-1,6-二甲基-1,6-二氮杂双环[4.4.0]癸烷离子(6)仅在甲基(霍夫曼方向)上去质子化。1,5-二氮杂三环[3.3.3.0]-十一烷(2),1、6-二氮杂三环[4.3.3.0]十二烷(3),1、6--二氮杂三环[4.4.3.0]十三烷(4)和1,6 -二氮杂三环[4.4.4.0]十四烷(5)离子产生桥头亚胺离子,该离子可能在分子内被跨环氨基捕获,或在外部被附加的亲核试剂捕获。与氰化物离子的反应给出了有关捕获序列的区域和立体化学的详细信息。尽管分子内/外部捕集确实具有竞争优势,但这些反应的产物(α-氨基铵离子和α-氨基腈)可以在不同的反应条
    DOI:
    10.1039/p29840000411
点击查看最新优质反应信息

文献信息

  • COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION
    申请人:Xu Lifeng
    公开号:US20140045779A1
    公开(公告)日:2014-02-13
    This invention relates with anti-tumor activities of new compounds containing an adamantyl group or analogs thereof. The invention also relates with the medication applications of anti-tumor and other diseases by this kind of compounds with the combination of S, P, T structures containing adamantyl group and the formation of stereoisomer, tautomers, prodrug, pharmaceutically acceptable salts, complex salts or solvates to their anticancer application and anticancer agents, which have the following general formula:
    这项发明涉及含有金刚烷基团或其类似物的新化合物的抗肿瘤活性。该发明还涉及利用这种含有金刚烷基团的S、P、T结构的化合物与立体异构体、互变异构体、前药、药用盐、复杂盐或溶剂化物的结合来治疗抗肿瘤和其他疾病的药物应用,这些抗肿瘤剂具有以下一般公式:
  • (METH)ACRYLATE MANUFACTURING METHOD
    申请人:TOAGOSEI CO., LTD
    公开号:US20180118658A1
    公开(公告)日:2018-05-03
    The present invention provides a (meth)acrylate manufacturing method characterized in that when manufacturing a (meth) acrylate by an ester exchange reaction between an alcohol and a monofunctional (meth)acrylate using catalyst A and catalyst B together, contact treatment of the ester exchange reaction product with adsorbent C is performed. Catalyst A: One or more kinds of compounds selected from a group consisting of cyclic tertiary amines with an azabicyclo structure and salts or complexes thereof, amidine and salts or complexes thereof, compounds with a pyridine ring and salts or complexes thereof, phosphines and salts or complexes thereof, and compounds with a tertiary diamine structure and salts or complexes thereof. Catalyst B: One or more kinds of compounds selected from a group consisting of compounds comprising zinc. Adsorbent C: One or more kinds of compounds selected from a group consisting of oxides and hydroxides comprising at least one of magnesium, aluminum and silicon.
    本发明提供了一种(甲基)丙烯酸酯制备方法,其特征在于通过在使用催化剂A和催化剂B一起进行醇和单官能基(甲基)丙烯酸酯之间的酯交换反应制备(甲基)丙烯酸酯时,对酯交换反应产物进行与吸附剂C的接触处理。催化剂A:从含有氮杂双环结构的环状三级胺及其盐或络合物、胺嘧啶及其盐或络合物、含有吡啶环的化合物及其盐或络合物、膦及其盐或络合物、以及含有三级二胺结构的化合物及其盐或络合物中选择的一种或多种化合物。催化剂B:从含锌化合物中选择的一种或多种化合物。吸附剂C:从含有镁、铝和硅中至少一种的氧化物和氢氧化物中选择的一种或多种化合物。
  • Phosphorus compound
    申请人:——
    公开号:US20030109736A1
    公开(公告)日:2003-06-12
    The phosphorus-containing compound of the present invention is represented by the following formula (I), (II) or (III): 1 wherein Z 1 , Z 2 and Z 3 each represents a cycloalkane, a cycloalkene, a polycyclic aliphatic hydrocarbon or an aromatic hydrocarbon rings which may have a substituent; R represents a halogen atom, a hydroxyl, a carboxyl, a halocarboxyl (haloformyl), an alkyl, an alkoxy, an alkenyl or an aryl groups; A represents a polyvalent group corresponding to an alkane; Y 1 , Y 2 and Y 3 each represents —O—, —S— or —NR 1 —, wherein R 1 represents a hydrogen atom or an alkyl group; k is an integer of to 6; m is an integer of 0 to 2; n is an integer of not less than 1; q is an integer of 0 to 5; r is 0 or 1; and S is an integer of 1 to 4. The phosphorus-containing compound is excellent in heat resistance and is useful as flame retardants, plasticizers, or stabilizers.
    本发明的含磷化合物由以下式(I)、(II)或(III)表示:其中Z1、Z2和Z3分别表示可能具有取代基团的环烷烃、环烯烃、多环脂肪烃或芳香烃环;R表示卤素原子、羟基、羧基、卤代羧基(卤甲酰基)、烷基、烷氧基、烯基或芳基;A表示对应于烷烃的多价基团;Y1、Y2和Y3分别表示—O—、—S—或—NR1—,其中R1表示氢原子或烷基;k为0至6的整数;m为0至2的整数;n为不少于1的整数;q为0至5的整数;r为0或1;S为1至4的整数。这种含磷化合物具有优异的耐热性,可用作阻燃剂、增塑剂或稳定剂。
  • MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD
    申请人:TOAGOSEI CO., LTD.
    公开号:US20170204044A1
    公开(公告)日:2017-07-20
    [Problem] The purpose of the present invention is to obtain a multifunctional (meth)acrylate with good yield by an ester exchange reaction of a polyhydric alcohol such as pentaerythritol or dipentaerythritol with a monofunctional (meth)acrylate. [Solution] A multifunctional (meth)acrylate manufacturing method characterized in that when manufacturing a multifunctional (meth)acrylate by an ester exchange reaction of a polyhydric alcohol with a monofunctional (meth)acrylate, catalyst (A) and catalyst (B) are used together. Catalyst (A): One or more kinds of compounds selected from a group consisting of cyclic tertiary amines with an azabicyclo structure or salts or complexes thereof, amidines or salts or complexes thereof, and compounds with a pyridine ring or salts or complexes thereof. Catalyst (B): One or more kinds of compounds selected from a group consisting of zinc-containing compounds.
    [问题] 本发明的目的是通过多元醇(如戊三醇或二戊三醇)与单官能基(甲基)丙烯酸酯的酯交换反应,获得产率高的多功能(甲基)丙烯酸酯。[解决方案] 一种多功能(甲基)丙烯酸酯制备方法,其特征在于,在通过多元醇与单官能基(甲基)丙烯酸酯的酯交换反应制备多功能(甲基)丙烯酸酯时,同时使用催化剂(A)和催化剂(B)。催化剂(A):选自具有氮杂双环结构的环三胺或其盐或络合物、酰胺或其盐或络合物以及吡啶环或其盐或络合物组成的群中的一种或多种化合物。催化剂(B):选自含锌化合物组成的群中的一种或多种化合物。
  • Process and apparatus for producing ketoisophorone
    申请人:Daicel Chemical Industries,Ltd.
    公开号:US20020055657A1
    公开(公告)日:2002-05-09
    &bgr;-isophorone is formed by isomerizing &agr;-isophorone in the presence of an isomerizing catalyst (an aliphatic C 5-20 polycarboxylic acid) in an isomerizing-reaction unit 1. The &bgr;-isophorone thus formed is oxidized with oxygen in an inert solvent in the presence of an oxidizing catalyst (a complex salt of a transition metal and an N,N′-disalicylidenediamine) in an oxidizing-reaction unit 2, thereby forming ketoisophorone. After removing a low-boiling point component, which is an impurity (non-conjugated cyclic ketone), from the reaction mixture using a distilling unit 3, a high-boiling component (oxidizing catalyst) is separated in a distilling unit 4 , and then ketoisophorone is separated from the solvent in the separation unit 5. Thereafter, the solvent containing 0 to 5,000 ppm (weight basis) of the impurities and substantially free from ketoisophorone is recycled to the oxidizing reaction through a recycling line 6. According to the present invention, the combination of the isomerizing reaction and the oxidizing reaction makes it possible to produce ketoisophorone from &agr;-isophorone while maintaining the activity of the oxidizing catalyst.
    &bgr;-异佛尔酮是通过在异构化反应装置1中,在异构化催化剂(脂肪族C5-20多羧酸)的存在下,将&agr;-异佛尔酮异构化形成的。然后,在氧化反应装置2中,在氧化催化剂(过渡金属的复杂盐和N,N'-二水杨基二胺)的存在下,将&Bgr;-异佛尔酮与氧气在惰性溶剂中氧化,从而形成酮异佛尔酮。使用蒸馏装置3从反应混合物中去除低沸点成分(非共轭环状酮)作为杂质后,使用蒸馏装置4分离高沸点成分(氧化催化剂),然后使用分离装置5从溶剂中分离出酮异佛尔酮。此后,含有0至5,000 ppm(重量基础)杂质且基本不含酮异佛尔酮的溶剂通过回收线6循环到氧化反应中。根据本发明,异构化反应和氧化反应的组合使得能够在保持氧化催化剂活性的同时从&agr;-异佛尔酮中生产酮异佛尔酮。
查看更多